Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 April 2021 | Story Nonsindiso Qwabe | Photo Sonia SMall

How has COVID-19 further widened the gender inequality gap in the workplace?

This was the central question addressed during the first instalment of a webinar series on Gender and Social Justice hosted by the Unit for Institutional Change and Social Justice at the University of the Free State (UFS). The webinar, which was hosted on the UFS Qwaqwa Campus on 29 March 2021, featured Prof Pearl Sithole, Qwaqwa Campus Vice-Principal: Academic and Research; Advocate Nthabiseng Sepanya-Mogale, Commissioner at the Commission for Gender Equality (CGE); and Tholo Motaung, skills trainer, moderator, and gender activist at the Vaal University of Technology as panellists. 

Prof Sithole said COVID-19 revealed the disparity that still exists between men and women in the workplace. “COVID-19 has been the magnifier. We’ve modernised quite a lot, but we’re still unequal in terms of gender. Why are we not progressing in terms of women moving forward towards equality when there has been so much progressive thinking in the political space, social justice space, as well as in the kind of feminism we have had in academia? Why are we actually not winning the battle of just regarding each other as equals?” 

Women hardest hit by COVID-19 lockdown

Advocate Sepanya-Mogale said the lockdown revealed the gender gap mostly through the significant impact it has had on South African women.

In 2020, 34% of the country’s workforce comprised women – a sharp decline of 9,8% from 43,8% in 2018.
“This decline is alarming and a clear indication of who becomes the first victims, but that is hardly talked about. A lot of women have experienced resistance from industries they had been serving diligently,” she said. She said women were often faced with the burden of integrating their work with increased care responsibilities for their children and sometimes also the elderly as primary caregivers. The double responsibility placed on women continues to re-enforce gender roles in our societies and further pushes away the success of closing the gap on gender equality prospects in our society.

Advocate Sepanya-Mogale said women were the hardest hit in most industries. In the beauty and tourism industry; air transportation; informal trading; and healthcare sector to name a few, women bore the brunt the most. “Women are the biggest employees on all economic levels in South Africa, especially the low-income and unskilled levels,” she said.
She said as the spread of the virus was likely to continue disrupting economic activity, all sectors of society needed to get involved and play their part.

“As disease outbreaks are not likely to disappear in the near future, proactive international action is required to not only save lives but to also protect economic prosperity. Academic institutions are authorities in terms of opening up new discussions, leading new debates, and putting critical issues at the centre of the table. Let us all do what we can so that we empower our people relevantly for the times we’re living in.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept